JW Jungwoa Pharmaceutical, Active Community... Stock Price -3.43%.
At this time, posts about JW Jungwoo Pharmaceutical are rapidly increasing on portals and securities communities. Today, foreigners have net sold 11,000 shares of JW Jungwoo Pharmaceutical, and institutions have net sold 5,000 shares, according to preliminary estimates. JW Jungwoo Pharmaceutical is known as a leading pharmaceutical company in the industry, famous for its infusion solutions.
As of 11:30 AM on the 21st, JW Jungwoo Pharmaceutical's stock price is 39,400 KRW, down 3.43% from the previous day, with a trading volume of 1,363,227 shares, which is 699.22% of the 5-day average trading volume.
In addition to JW Jungwoo Pharmaceutical, posts by investors are also rapidly increasing for Nara M&D (051490), Cheonbo (278280), and DNA Link (127120).
Hot Picks Today
!["Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"](https://cwcontent.asiae.co.kr/asiaresize/93/2026051507261063923_1778797570.png)
"Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- While Everyone Focused on Samsung and Nix, This Company Soared 50%... Hit Record Highs for 4 Days [Weekend Money]
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Semiconductor Society: "Samsung Strike Would Devastate Industry... Urges Amicable Settlement"
- "Target Price Set at 970,000 Won"... Top Investors Already Watching, Only an 'Uptrend' Remains [Weekend Money]
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
